HEADER TRANSFERASE 11-MAY-00 1C8K TITLE FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE TITLE 2 INHIBITOR SITE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (GLYCOGEN PHOSPHORYLASE); COMPND 3 CHAIN: A; COMPND 4 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 TISSUE: MUSCLE KEYWDS GLYCOGEN METABOLISM, GLYCOGEN PHOSPHORYLASE B, INHIBITION, INHIBITOR KEYWDS 2 BINDING SITE, ANTITUMOUR AGENT, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.G.OIKONOMAKOS,S.E.ZOGRAPHOS,V.T.SKAMNAKI,K.E.TSITSANOU,L.N.JOHNSON REVDAT 5 27-DEC-23 1C8K 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 1C8K 1 VERSN REVDAT 3 24-FEB-09 1C8K 1 VERSN REVDAT 2 29-NOV-00 1C8K 1 JRNL REVDAT 1 24-MAY-00 1C8K 0 JRNL AUTH N.G.OIKONOMAKOS,J.B.SCHNIER,S.E.ZOGRAPHOS,V.T.SKAMNAKI, JRNL AUTH 2 K.E.TSITSANOU,L.N.JOHNSON JRNL TITL FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT JRNL TITL 2 THE INHIBITOR SITE. JRNL REF J.BIOL.CHEM. V. 275 34566 2000 JRNL REFN ISSN 0021-9258 JRNL PMID 10924512 JRNL DOI 10.1074/JBC.M004485200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.G.OIKONOMAKOS,K.E.TSITSANOU,S.E.ZOGRAPHOS,V.T.SKAMNAKI, REMARK 1 AUTH 2 S.GOLDMANN,H.BISCHOFF REMARK 1 TITL ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY THE REMARK 1 TITL 2 POTENTIAL ANTIDIABETIC DRUG 3-ISOPROPYL REMARK 1 TITL 3 4-(2-CHLOROPHENYL)-1,4-DIHYDRO-1-ETHYL-2-METHYL-PYRIDINE-3, REMARK 1 TITL 4 5,6-TRICARBOXYLATE REMARK 1 REF PROTEIN SCI. V. 8 1930 1999 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.E.ZOGRAPHOS,N.G.OIKONOMAKOS,K.E.TSITSANOU,D.D.LEONIDAS, REMARK 1 AUTH 2 E.D.CHRYSINA,V.T.SKAMNAKI,H.BISCHOFF,S.GOLDMANN,K.A.WATSON, REMARK 1 AUTH 3 L.N.JOHNSON REMARK 1 TITL THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN REMARK 1 TITL 2 ALKYLDIHYDROPYRIDINE-DICARBOXYLIC ACID COMPOUND, A NOVEL AND REMARK 1 TITL 3 POTENT INHIBITOR REMARK 1 REF STRUCTURE V. 5 1413 1997 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(97)00292-X REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 95385 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : R FREE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6749 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 331 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.360 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.720 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 1.500 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.000 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1C8K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-00. REMARK 100 THE DEPOSITION ID IS D_1000001469. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 287.0 REMARK 200 PH : 6.70 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X31 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.05 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 95442 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 29.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.64000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.70 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.05000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.20000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.20000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.07500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.20000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.20000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.02500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.20000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.20000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.07500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.20000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.20000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.02500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.05000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 DIMER IS THE PHYSIOLOGICALLY ACTIVE MOLECULE REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 7420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 59020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 116.10000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 ARG A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 4 REMARK 465 SER A 5 REMARK 465 ASP A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 LYS A 9 REMARK 465 ARG A 10 REMARK 465 LYS A 11 REMARK 465 GLN A 12 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 60 CD - NE - CZ ANGL. DEV. = 8.7 DEGREES REMARK 500 ARG A 60 NE - CZ - NH1 ANGL. DEV. = 6.8 DEGREES REMARK 500 ARG A 60 NE - CZ - NH2 ANGL. DEV. = -12.7 DEGREES REMARK 500 LYS A 554 N - CA - C ANGL. DEV. = 16.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 14 -179.85 154.65 REMARK 500 VAL A 15 53.41 -95.87 REMARK 500 ALA A 19 67.51 -102.13 REMARK 500 LEU A 131 43.44 -84.10 REMARK 500 TYR A 203 -135.20 60.61 REMARK 500 SER A 210 -79.20 22.78 REMARK 500 GLN A 211 59.83 -104.72 REMARK 500 ASP A 251 -101.89 -84.74 REMARK 500 PHE A 252 -36.76 -39.64 REMARK 500 ASN A 253 49.16 -77.59 REMARK 500 LEU A 254 -39.38 164.95 REMARK 500 ASP A 256 85.75 -69.22 REMARK 500 ASN A 258 63.28 96.28 REMARK 500 VAL A 259 151.66 63.08 REMARK 500 LEU A 271 -35.24 -150.26 REMARK 500 PRO A 281 34.38 -82.13 REMARK 500 SER A 313 -72.21 -81.37 REMARK 500 SER A 314 -121.21 26.71 REMARK 500 CYS A 318 -60.07 -152.46 REMARK 500 ARG A 319 -105.32 -155.94 REMARK 500 ASP A 320 -147.97 70.02 REMARK 500 VAL A 322 105.97 62.92 REMARK 500 ARG A 323 109.53 134.66 REMARK 500 THR A 324 77.84 -47.75 REMARK 500 ASP A 339 -170.74 74.69 REMARK 500 THR A 466 -98.25 -119.39 REMARK 500 LEU A 492 -70.89 -149.60 REMARK 500 ASP A 514 64.58 -155.50 REMARK 500 LYS A 554 102.20 51.90 REMARK 500 VAL A 555 33.46 162.95 REMARK 500 HIS A 556 146.01 37.23 REMARK 500 LYS A 568 173.18 177.20 REMARK 500 SER A 674 -62.33 -146.16 REMARK 500 LYS A 772 64.66 33.16 REMARK 500 PRO A 835 69.47 -45.49 REMARK 500 ALA A 836 172.27 47.27 REMARK 500 ASP A 838 115.44 -9.11 REMARK 500 GLU A 839 -92.61 1.11 REMARK 500 LYS A 840 132.20 55.70 REMARK 500 ILE A 841 87.63 -153.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: FLA REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: FLAVOPIRIDOL BINDS AT THE INHIBITOR SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLP A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CPB A 940 DBREF 1C8K A 1 842 UNP P00489 PHS2_RABIT 1 842 SEQADV 1C8K ILE A 380 UNP P00489 LEU 380 CONFLICT SEQRES 1 A 842 SER ARG PRO LEU SER ASP GLN GLU LYS ARG LYS GLN ILE SEQRES 2 A 842 SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL THR GLU SEQRES 3 A 842 LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE THR LEU SEQRES 4 A 842 VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP TYR TYR SEQRES 5 A 842 PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU VAL GLY SEQRES 6 A 842 ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU LYS ASP SEQRES 7 A 842 PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE TYR MET SEQRES 8 A 842 GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU ALA LEU SEQRES 9 A 842 GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU GLY LEU SEQRES 10 A 842 ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP ALA GLY SEQRES 11 A 842 LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA CYS PHE SEQRES 12 A 842 LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA TYR GLY SEQRES 13 A 842 TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN GLN LYS SEQRES 14 A 842 ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP ASP TRP SEQRES 15 A 842 LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG PRO GLU SEQRES 16 A 842 PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL GLU HIS SEQRES 17 A 842 THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN VAL VAL SEQRES 18 A 842 LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY TYR ARG SEQRES 19 A 842 ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER ALA LYS SEQRES 20 A 842 ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN VAL GLY SEQRES 21 A 842 GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU ALA GLU SEQRES 22 A 842 ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN PHE PHE SEQRES 23 A 842 GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR PHE VAL SEQRES 24 A 842 VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG PHE LYS SEQRES 25 A 842 SER SER LYS PHE GLY CYS ARG ASP PRO VAL ARG THR ASN SEQRES 26 A 842 PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN LEU ASN SEQRES 27 A 842 ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU MET ARG SEQRES 28 A 842 VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP LYS ALA SEQRES 29 A 842 TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR ASN HIS SEQRES 30 A 842 THR VAL ILE PRO GLU ALA LEU GLU ARG TRP PRO VAL HIS SEQRES 31 A 842 LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN ILE ILE SEQRES 32 A 842 TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL ALA ALA SEQRES 33 A 842 ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG MET SER SEQRES 34 A 842 LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN MET ALA SEQRES 35 A 842 HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN GLY VAL SEQRES 36 A 842 ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR ILE PHE SEQRES 37 A 842 LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE GLN ASN SEQRES 38 A 842 LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU VAL LEU SEQRES 39 A 842 CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU ARG ILE SEQRES 40 A 842 GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU ARG LYS SEQRES 41 A 842 LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE ARG ASP SEQRES 42 A 842 VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS PHE ALA SEQRES 43 A 842 ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE ASN PRO SEQRES 44 A 842 ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE HIS GLU SEQRES 45 A 842 TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL ILE THR SEQRES 46 A 842 LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS PHE VAL SEQRES 47 A 842 VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA ALA PRO SEQRES 48 A 842 GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU ILE THR SEQRES 49 A 842 ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL VAL GLY SEQRES 50 A 842 ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR ARG VAL SEQRES 51 A 842 SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP LEU SER SEQRES 52 A 842 GLU GLN ILE SER THR ALA GLY THR GLU ALA SER GLY THR SEQRES 53 A 842 GLY ASN MET LYS PHE MET LEU ASN GLY ALA LEU THR ILE SEQRES 54 A 842 GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA GLU GLU SEQRES 55 A 842 ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET ARG VAL SEQRES 56 A 842 GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR ASN ALA SEQRES 57 A 842 GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG GLN ILE SEQRES 58 A 842 ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO LYS GLN SEQRES 59 A 842 PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU MET HIS SEQRES 60 A 842 HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU GLU TYR SEQRES 61 A 842 VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR LYS ASN SEQRES 62 A 842 PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN ILE ALA SEQRES 63 A 842 THR SER GLY LYS PHE SER SER ASP ARG THR ILE ALA GLN SEQRES 64 A 842 TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER ARG GLN SEQRES 65 A 842 ARG LEU PRO ALA PRO ASP GLU LYS ILE PRO HET PLP A 999 15 HET CPB A 940 28 HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM CPB 2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1- HETNAM 2 CPB METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN CPB FLAVOPIRIDOL FORMUL 2 PLP C8 H10 N O6 P FORMUL 3 CPB C21 H20 CL N O5 FORMUL 4 HOH *331(H2 O) HELIX 1 1 VAL A 21 PHE A 37 1 17 HELIX 2 2 PRO A 48 GLU A 76 1 29 HELIX 3 3 LEU A 95 LEU A 102 1 8 HELIX 4 4 GLU A 105 GLN A 114 1 10 HELIX 5 5 MET A 119 ILE A 125 1 7 HELIX 6 6 GLY A 135 THR A 149 1 15 HELIX 7 7 PRO A 194 PHE A 196 5 3 HELIX 8 8 TYR A 262 ARG A 269 1 8 HELIX 9 9 GLU A 273 SER A 276 5 4 HELIX 10 10 GLU A 290 LYS A 312 1 23 HELIX 11 11 PHE A 326 LYS A 332 5 7 HELIX 12 12 THR A 340 ASP A 355 5 16 HELIX 13 13 TRP A 361 THR A 371 1 11 HELIX 14 14 PRO A 381 ALA A 383 5 3 HELIX 15 15 VAL A 389 LEU A 395 1 7 HELIX 16 16 PRO A 397 ALA A 417 1 21 HELIX 17 17 VAL A 422 MET A 428 1 7 HELIX 18 18 MET A 441 GLY A 448 1 8 HELIX 19 19 ARG A 457 LYS A 465 1 9 HELIX 20 20 LYS A 469 LEU A 474 1 6 HELIX 21 21 PRO A 476 LYS A 478 5 3 HELIX 22 22 PRO A 488 TRP A 491 1 4 HELIX 23 23 PRO A 497 ILE A 507 1 11 HELIX 24 24 GLU A 510 ILE A 512 5 3 HELIX 25 25 LEU A 515 TYR A 524 5 10 HELIX 26 26 GLU A 528 GLU A 552 1 25 HELIX 27 27 GLN A 576 LYS A 592 1 17 HELIX 28 28 HIS A 614 HIS A 632 1 19 HELIX 29 29 VAL A 650 ALA A 659 1 10 HELIX 30 30 GLY A 677 ASN A 684 1 8 HELIX 31 31 GLY A 694 ALA A 703 5 10 HELIX 32 32 GLU A 705 ASN A 707 5 3 HELIX 33 33 VAL A 715 ARG A 724 1 10 HELIX 34 34 ALA A 728 ARG A 734 5 7 HELIX 35 35 PRO A 736 SER A 747 1 12 HELIX 36 36 PRO A 755 HIS A 767 5 13 HELIX 37 37 VAL A 773 LYS A 792 5 20 HELIX 38 38 PRO A 794 THR A 807 1 14 HELIX 39 39 GLY A 809 PHE A 811 5 3 HELIX 40 40 SER A 813 GLU A 823 1 11 SHEET 1 A 7 GLU A 190 ARG A 193 0 SHEET 2 A 7 VAL A 221 PRO A 231 -1 N ASP A 227 O LYS A 191 SHEET 3 A 7 VAL A 238 ALA A 248 -1 N LYS A 247 O LEU A 222 SHEET 4 A 7 ALA A 154 ILE A 159 1 N GLY A 156 O THR A 240 SHEET 5 A 7 ARG A 81 LEU A 85 1 N ILE A 82 O TYR A 155 SHEET 6 A 7 VAL A 333 ASN A 338 1 N ALA A 334 O ARG A 81 SHEET 7 A 7 CYS A 372 THR A 375 1 N ALA A 373 O ILE A 335 SHEET 1 B 2 ASN A 167 CYS A 171 0 SHEET 2 B 2 TRP A 174 GLU A 178 -1 N GLU A 178 O ASN A 167 SHEET 1 C 2 LEU A 198 PHE A 202 0 SHEET 2 C 2 GLN A 219 ALA A 223 -1 N ALA A 223 O LEU A 198 SHEET 1 D 2 ARG A 205 HIS A 208 0 SHEET 2 D 2 ALA A 213 VAL A 216 -1 N VAL A 216 O ARG A 205 SHEET 1 E 2 ARG A 386 PRO A 388 0 SHEET 2 E 2 ARG A 438 ASN A 440 -1 N ILE A 439 O TRP A 387 SHEET 1 F 2 VAL A 452 GLY A 454 0 SHEET 2 F 2 PHE A 479 ASN A 481 1 N GLN A 480 O VAL A 452 SHEET 1 G 3 LEU A 562 VAL A 567 0 SHEET 2 G 3 ARG A 601 GLY A 606 1 N THR A 602 O LEU A 562 SHEET 3 G 3 LEU A 640 PHE A 644 1 N ARG A 641 O ARG A 601 SHEET 1 H 2 LEU A 662 GLN A 665 0 SHEET 2 H 2 LEU A 687 GLY A 690 1 N LEU A 687 O SER A 663 LINK NZ LYS A 680 C4A PLP A 999 1555 1555 1.34 SITE 1 FLA 2 PHE A 285 TYR A 613 SITE 1 AC1 18 GLY A 134 TRP A 491 LYS A 568 LYS A 574 SITE 2 AC1 18 TYR A 648 ARG A 649 VAL A 650 GLY A 675 SITE 3 AC1 18 THR A 676 GLY A 677 LYS A 680 HOH A1062 SITE 4 AC1 18 HOH A1071 HOH A1115 HOH A1116 HOH A1121 SITE 5 AC1 18 HOH A1128 HOH A1224 SITE 1 AC2 11 ASN A 284 PHE A 285 ILE A 380 GLU A 382 SITE 2 AC2 11 GLU A 572 ALA A 610 GLY A 612 TYR A 613 SITE 3 AC2 11 ARG A 770 HOH A1035 HOH A1306 CRYST1 128.400 128.400 116.100 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007788 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007788 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008613 0.00000